Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:48:32 EST Sun 15 Feb 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:NRX - NurExone Biologic Inc. - https://www.nurexone.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NRX - V  1.00.66·0.6933.00.68+0.057.976.450330.64  0.69  0.641.14  0.5515:03:34Feb 1015 min RT 2¢
TSX-V - V1.00.66·0.6933.00.68+0.057.938.926120.64  0.69  0.641.14  0.5515:03:3415 min
NEO ATS - U 0.68+0.057.93.5250.64  0.68  0.6415:03:3415 min
Omega - O 0.68+0.057.95.0320.64  0.68  0.6409:50:3415 min
CX2 - H 0.67+0.046.319.513100.64  0.68  0.6415:03:2015 min
CXD - D 0.630.501    Feb 1015 min
Lynx - Y 0.68+0.057.98.0520.68  0.68  0.6809:50:3415 min
CS2 - S 0.68+0.057.91.0110.68  0.68  0.6809:50:3415 min

Recent Trades - Last 10 of 33
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:03:34U0.680.0550080 National Bank2 RBCK
15:03:34V0.680.051,00080 National Bank80 National BankK
15:03:34U0.680.0550080 National Bank2 RBCK
15:03:20H0.670.045001 Anonymous80 National BankK
15:03:20V0.670.041,00084 ITG8480 National BankK
15:03:20V0.670.0450084 ITG8480 National BankK
15:03:20V0.670.042,00079 CIBC80 National BankK
14:40:40H0.680.053,00084 ITG841 AnonymousK
12:00:40H0.680.051,50014 Virtu ITG1 AnonymousK
11:06:16H0.680.055001 Anonymous1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-02-10 16:04C:NRX0.64News ReleaseNurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production
2026-01-30 17:29C:NRX0.66News ReleaseNurexone Biologic appoints Gabbai director
2025-12-19 16:04C:NRX0.69News ReleaseNurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
2025-12-12 17:02C:NRX0.61News ReleaseNurexone prepares small-scale manufacturing for ExoPTEN
2025-11-28 09:15C:NRX0.71News ReleaseNurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-26 17:18C:NRX0.71SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-26 17:12C:NRX0.71SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-12 22:03C:NRX0.70News ReleaseNurexone receives $3.18-million from warrant exercise
2025-11-04 02:56C:NRX0.69News ReleaseNurexone joins BioFab Startup Lab
2025-10-21 16:04C:NRX0.78News ReleaseNurExone Invited Presenter at Precision EV Forum in Cambridge, UK
2025-10-08 18:27C:NRX0.90News ReleaseNurexone shows vision recovery in glaucoma study
2025-09-17 20:52C:NRX1.07Private PlacementNurexone Biologic 930,376-share private placement
2025-09-17 04:55C:NRX1.05News ReleaseNurexone to open exosome production facility in Indiana
2025-09-12 01:22C:NRX0.90News ReleaseNurexone Biologic receives patent in Israel
2025-09-09 21:06C:NRX0.84Private PlacementNurexone Biologic 1,258,072-share private placement
2025-09-08 16:30C:NRX0.81News ReleaseNurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
2025-08-28 08:15C:NRX0.83News ReleaseNurExone Biologic Inc. Announces Second Quarter 2025 Financial Results
2025-08-20 19:36C:NRX0.79News ReleaseNurexone releases preclinical ExoPTEN imaging results
2025-08-08 17:30C:NRX0.69News ReleaseNurexone says exosomes beat industry healing standard
2025-07-08 16:24C:NRX0.67News ReleaseNew ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model